Axogen, Inc.

AXGN ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-10.4M $-14.4M $-13.4M $-17.7M $-14.6M $-9.4M $-9.2M $-5.4M
Depreciation & Amortization — — — $153.7K $79.2K $187.7K $273.5K —
Depreciation $488.0K $362.0K $203.1K $153.7K — — $273.5K $306.3K
Amortization $79.0K $75.0K $45.8K $45.2K $59.1K $127.1K $67.1K $46.8K
Stock-Based Compensation $3.6M $1.4M $1.3M $956.4K $671.9K $495.1K $250.0K $187.5K
Net Cash from Operating Activities $-9.2M $-11.2M $-13.1M $-10.5M $-10.4M $-8.7M $-7.1M $-3.9M
Investing Activities
Capital Expenditures $1.1M $931.0K $408.8K $542.0K $178.8K $48.5K $20.6K —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-1.3M $-1.2M $-555.5K — — $-127.3K $7.1M $-72.0K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $17.0M $16.5M $31.3M — — $14.5M $6.4M $5.5M
Net Change in Cash $6.5M $4.1M $17.7M $-11.9M $6.2M $5.7M $6.4M $1.5M
Free Cash Flow $-10.3M $-12.2M $-13.5M $-11.0M $-10.6M $-8.7M $-7.1M —
← Newer Page 2 of 2 Older →